1. The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review

   • Jayne S. Wilson
   • Caroline Main
   • Barry Pizer

   Review Open access 31 January 2024 Pages: 1 - 34

   

2. Correction to: The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review

   • Jayne S. Wilson
   • Caroline Main
   • Barry Pizer

   Correction Open access 05 March 2024 Pages: 35 - 37

3. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review

   • Eric Singh
   • Muhammet Enes Gurses
   • Ashish H. Shah

   Review 31 January 2024 Pages: 39 - 47

   

4. Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review

   • Eric Singh
   • Muhammet Enes Gurses
   • Ashish H. Shah

   Correction 06 March 2024 Pages: 49 - 49

5. Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery

   • Motoyuki Umekawa
   • Yuki Shinya
   • Nobuhito Saito

   Research Open access 18 February 2024 Pages: 51 - 61

   

6. CPLX2 is a novel tumor suppressor and improves the prognosis in glioma

   • Yuanbing Chen
   • Jieling Ning
   • Jun Huang

   Research 01 March 2024 Pages: 63 - 74

   

7. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma

   • Yukina Shirai
   • Toshihide Ueno
   • Shinji Kohsaka

   Research Open access 16 February 2024 Pages: 75 - 88

   

8. Validation of a methylation-based signature for subventricular zone involvement in glioblastoma

   • Felix Ehret
   • Oliver Zühlke
   • David Kaul

   Research Open access 20 February 2024 Pages: 89 - 97

   

9. Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype

   • Antonio Dono
   • Jose Torres
   • Yoshua Esquenazi

   Research 13 February 2024 Pages: 99 - 109

   

10. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes

    • Thais Baccili Cury Megid
    • Zeynep Baskurt
    • Elena Elimova

    Research Open access 19 February 2024 Pages: 111 - 122

    

11. Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study

    • Bin Wang
    • Yimei Liu
    • Xiaowu Deng

    Research Open access 01 February 2024 Pages: 123 - 132

    

12. Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas

    • Naureen Keric
    • Harald Krenzlin
    • Florian Ringel

    Research Open access 07 February 2024 Pages: 133 - 144

    

13. The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study

    • Vincenzo Di Nunno
    • Giuseppe Lombardi
    • Enrico Franceschi

    Research 08 March 2024 Pages: 145 - 154

    

14. Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection

    • David Wasilewski
    • Julia Onken
    • Philip Bischoff

    Research Open access 15 February 2024 Pages: 155 - 167

    

15. Effect of sarcopenia and frailty on outcomes among patients with brain metastases

    • Mervyn Jun Rui Lim
    • Zheting Zhang
    • Tseng Tsai Yeo

    Case Study 02 March 2024 Pages: 169 - 180

    

16. The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab

    • Pushan Dasgupta
    • Alexander Ou
    • Nazanin K. Majd

    Case Study 19 February 2024 Pages: 181 - 188

    

17. CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

    • Manali Ranade
    • Sridhar Epari
    • Tejpal Gupta

    Case Study 24 January 2024 Pages: 189 - 198

    

18. Correction to: CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

    • Manali Ranade
    • Sridhar Epari
    • Tejpal Gupta

    Correction 15 February 2024 Pages: 199 - 199

19. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review

    • Yasuhito Kegoya
    • Yoshihiro Otani
    • Isao Date

    Case Study Open access 01 March 2024 Pages: 201 - 210

    

20. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors

    • Lisa M. Arnold
    • Yoji Hoshina
    • Joe Mendez

    Case Study 16 February 2024 Pages: 211 - 217

    

21. Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery

    • Andrew Fairchild
    • Joseph K. Salama
    • Scott R. Floyd

    Case Study 10 February 2024 Pages: 219 - 227

    

22. Stereotactic radiosurgery for intracranial adenoid cystic carcinoma

    • Jason P. Sheehan
    • Raj Singh
    • Daniel M. Trifiletti

    Correspondence 16 February 2024 Pages: 229 - 230

    

23. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma

    • Jason P. Sheehan
    • Georgios Mantziaris
    • Adomas Bunevicius

    Correspondence 16 February 2024 Pages: 231 - 232